Brian Morgan, MD
Ophthalmology · Edmond, OKNPI 1083617054
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.1% of the total across 75 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Alcon at 38.6% of the total.
Across 75 payments — averaging $41.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Ocular Therapeutix, Inc.$619
- Glaukos Corporation$368
- Rxsight Inc$222
- Sight Sciences, Inc.$173
- Abbott$158
- plus $370 from 6 others
What the payments were for
- Speaking & faculty fees$281%
- Food & beverage$3,08199%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 22 | $1,199 |
| Ocular Therapeutix, Inc. | 19 | $619 |
| Glaukos Corporation | 3 | $368 |
| Rxsight Inc | 6 | $222 |
| Sight Sciences, Inc. | 3 | $173 |
| Abbott | 10 | $158 |
| AbbVie | 7 | $135 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $119 |
| The Cameron-ehlen Group, Inc. | 1 | $73 |
| Omeros Corporation | 1 | $15 |
| NEW World Medical,inc. | 1 | $15 |
| IBSA Pharma Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- DEXTENZA$403
- Clareon$231
- iStent Trabecular Micro-Bypass Stent System$144
- iStent infinite Trabecular Micro-Bypass System Model iS3$144
- iStent Inject Trabecular Micro-Bypass System$144
- AcrySof IQ PanOptix$142
- PanOptix$130
- OMNI(R) SURGICAL SYSTEM (US)$127
- SION SURGICAL INSTRUMENT$127
- KXL System$125
- Photrexa$125
- Clareon PanOptix Pro$123
- LenSx$121
- RXSIGHT CONTACT LENS$120
- RXSIGHT INJECTOR HANDPIECE$120
- RXSIGHT INJECTOR CARTRIDGE$120
- RXSIGHT LIGHT ADJUSTABLE LENS (RXLAL)$120
- RXSIGHT LIGHT DELIVERY DEVICE (LDD)$120
- STELLARIS$119
- Hydrus Microstent$117
How this compares
$3,109 in reported general payments places this provider in the 80th percentile of 183 ophthalmology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 54 | $1,709 |
| Ketorolac Tromethamine | 56 | $863 |
| Ciprofloxacin Hcl | 54 | $634 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Edmond
- Don NguyenEdmond$36K
- Bradley BrittonEdmond$25K
- Jeffrey ShaverEdmond$11K
- Whitney PotterEdmond$10K
- Michael HogueEdmond$6K
- Vincent VenincasaEdmond$5K
- Jared JacksonEdmond$3K
- Ronald RebenitschOklahoma City$141K
- Kyle RogersEnid$19K
- Edward JonesOklahoma City$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.